Gradient Pharmaceuticals
Houston, US · Founded 2016 · Delaware corporation
Founders & leadership
MM
Martin MartinovExecutive
VA
Valentin AngelkovExecutive
Board
MD
Max DuckworthBoard director
Reported raises · per SEC filings
Form D private placements$850K disclosed across 1 round · 2016
▶$850KraisedOct 2016 · 1 investors · BiotechnologyRule 506(b)
▶$850KraisedOct 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Max DuckworthDirector
- Martin MartinovExecutive Officer, Director
- Valentin AngelkovExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $850K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Gradient Pharmaceuticals raised?
- Gradient Pharmaceuticals has disclosed $850K raised across 1 round.
- Where is Gradient Pharmaceuticals headquartered?
- Gradient Pharmaceuticals is headquartered in Houston, US.